These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 15733882

  • 1. Low-dose secnidazole in the treatment of bacterial vaginosis.
    Núñez JT, Gómez G.
    Int J Gynaecol Obstet; 2005 Mar; 88(3):281-5. PubMed ID: 15733882
    [Abstract] [Full Text] [Related]

  • 2. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis.
    Schwebke JR, Morgan FG, Koltun W, Nyirjesy P.
    Am J Obstet Gynecol; 2017 Dec; 217(6):678.e1-678.e9. PubMed ID: 28867602
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis.
    Chavoustie SE, Gersten JK, Samuel MJ, Schwebke JR.
    J Womens Health (Larchmt); 2018 Apr; 27(4):492-497. PubMed ID: 29323627
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment for Symptomatic Bacterial Vaginosis: ARandomized Controlled Trial.
    Tariq N, Basharat A, Khan DH, Fahim A, Khan MH.
    J Coll Physicians Surg Pak; 2017 Nov; 27(11):686-689. PubMed ID: 29132478
    [Abstract] [Full Text] [Related]

  • 7. Treatment of bacterial vaginosis with oral or vaginal ornidazole, secnidazole and metronidazole.
    Saraçoğlu F, Göl K, Sahin I, Türkkani B, Atalay C, Oztopçu C.
    Int J Gynaecol Obstet; 1998 Jul; 62(1):59-61. PubMed ID: 9722127
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of single dose of oral secnidazole 2 g in treatment of bacterial vaginosis: A systematic review and meta-analysis.
    Elghazaly SM, Hamam KM, Badawy MM, Yakoub Agha NA, Samy A, Abbas AM.
    Eur J Obstet Gynecol Reprod Biol; 2019 Jul; 238():125-131. PubMed ID: 31129560
    [Abstract] [Full Text] [Related]

  • 9. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream.
    Ferris DG, Litaker MS, Woodward L, Mathis D, Hendrich J.
    J Fam Pract; 1995 Nov; 41(5):443-9. PubMed ID: 7595261
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis.
    Hillier SL, Lipinski C, Briselden AM, Eschenbach DA.
    Obstet Gynecol; 1993 Jun; 81(6):963-7. PubMed ID: 8497364
    [Abstract] [Full Text] [Related]

  • 11. Treatment of bacterial vaginosis: a multicenter, double-blind, double-dummy, randomised phase III study comparing secnidazole and metronidazole.
    Bohbot JM, Vicaut E, Fagnen D, Brauman M.
    Infect Dis Obstet Gynecol; 2010 Jun; 2010():. PubMed ID: 20885970
    [Abstract] [Full Text] [Related]

  • 12. An Integrated Efficacy and Safety Analysis of Single-Dose Secnidazole 2 g in the Treatment of Bacterial Vaginosis.
    Pentikis H, Adetoro N, Tipping D, Levy S.
    Reprod Sci; 2020 Feb; 27(2):523-528. PubMed ID: 32046418
    [Abstract] [Full Text] [Related]

  • 13. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy.
    Bradshaw CS, Tabrizi SN, Fairley CK, Morton AN, Rudland E, Garland SM.
    J Infect Dis; 2006 Sep 15; 194(6):828-36. PubMed ID: 16941351
    [Abstract] [Full Text] [Related]

  • 14. Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis.
    Gillis JC, Wiseman LR.
    Drugs; 1996 Apr 15; 51(4):621-38. PubMed ID: 8706597
    [Abstract] [Full Text] [Related]

  • 15. [Efficacy of 5-nitroimidazole derivatives in treatment of bacterial vaginosis].
    Wang FM, Qian XD, Xu H, Yu HY.
    Zhonghua Yi Xue Za Zhi; 2008 Aug 12; 88(31):2201-3. PubMed ID: 19080672
    [Abstract] [Full Text] [Related]

  • 16. Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment.
    Nyirjesy P, Schwebke JR.
    Future Microbiol; 2018 Apr 12; 13():507-524. PubMed ID: 29327947
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the Effect of Vaginal Zataria multiflora Cream and Oral Metronidazole Pill on Results of Treatments for Vaginal Infections including Trichomoniasis and Bacterial Vaginosis in Women of Reproductive Age.
    Abdali K, Jahed L, Amooee S, Zarshenas M, Tabatabaee H, Bekhradi R.
    Biomed Res Int; 2015 Apr 12; 2015():683640. PubMed ID: 26266260
    [Abstract] [Full Text] [Related]

  • 18. Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial.
    Kissinger P, Muzny CA, Mena LA, Lillis RA, Schwebke JR, Beauchamps L, Taylor SN, Schmidt N, Myers L, Augostini P, Secor WE, Bradic M, Carlton JM, Martin DH.
    Lancet Infect Dis; 2018 Nov 12; 18(11):1251-1259. PubMed ID: 30297322
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study.
    Muzny CA, Schwebke JR, Nyirjesy P, Kaufman G, Mena LA, Lazenby GB, Van Gerwen OT, Graves KJ, Arbuckle J, Carter BA, McMahon CP, Eder S, Shaw J, Pandey B, Chavoustie SE.
    Clin Infect Dis; 2021 Sep 15; 73(6):e1282-e1289. PubMed ID: 33768237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.